Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 05/22/2013

Company Name Symbol %Change
ALLIANCE FIB AFOP
9.31%
SONIC FOUNDR SOFO
7.77%
TRI TECH HOL TRIT
6.62%
A M R CP AAMRQ
4.52%
FLOWERS FOOD FLO
4.31%
Zacks ZACKS.COM
PROFIT from the PROS

Tactics that Work in Good Markets and Bad
Manage your PFP
Free Subscription
Change of Address
Unsubscribe
--

Dear Subscriber,

For-profit education companies have had a reputation as being counter-cyclical. As I discuss in this week’s Industry Rank Analysis, bullish third-quarter earnings reports have reinforced this reputation:

http://at.zacks.com/?id=4699

Staying on the topic of education, Steve Reitmeister and Alex Kolb created a video showing how to use Zacks.com to find the best growth & income stocks. This conservative investing strategy is a good option for the current market environment.

http://at.zacks.com/?id=4336

Wishing you prosperity,
Charles Rotblut, CFA
Senior Market Analyst & Editor
Profit From the Pros

 

 

Today's Top Stories: Thursday- November 06, 2008

ZACKS RANK BUY STOCKS

  • Aggressive Growth - Varian Medical Systems, Inc. (VAR) just reported another earnings surprise along with increased revenue. Learn More...
     
  • Growth & Income - Abbott Laboratories (ABT) saw all 12 covering analysts boost full-year earnings estimates. Forecasts of $3.32 per share were increased from last month’s $3.27. Learn More...
     
  • Momentum - Apollo Group's (APOL) share price has been rallying since the company reported excellent fourth-quarter results in late October. Estimates continue to rise, with the next-year estimate projecting 18% earnings growth. Learn More...
     
  • Value - Omnicare, Inc. (OCR) raised full-year guidance after a strong third-quarter as pharmacy services for the elderly continue to see growth even in a rocky economic environment. Learn More...
     
Sponsor

Exploit the Surprise

Leverage the factor that makes stock prices move the most. Learn how to take advantage of positive earnings surprises to drive gains. In today’s market active portfolio management is your key. Discover how to use earnings releases to reveal a series of small winners to generate substantial returns. Get started today with Zacks Surprise Trader.

http://at.zacks.com/?id=4949


BEST OF ZACKS EQUITY RESEARCH
  • Bull Of The Day: Osiris Pharmaceuticals (OSIR)
    Full Zacks research report: Learn More...
  • Bear Of The Day: Cymer Inc. (CYMI)
    Full Zacks research report: Learn More...
  • Analyst Interview: Post-Election, Don't Expect Quick Turnaround
    The stock market will turn well before the economy turns, usually about six months before the economy actually starts to improve. But we think it will take much longer than six months to get this economy turned around. We look at KMB, DLM, UL, PFE and JNJ Learn more...
  • Obama: Energy and Healthcare
  • What’s Changed (& What Has Not)?

 


EDUCATION: Growth & Income

The Risk of a Dividend Cut. Learn more...

PeopleAndPicks.com:

"JoeJustJoe" recently made a Buy call on SRS and Sell calls on CLHB and SOHU. Take a look at all of JoeJustJoe's positions: Learn More...

OTHER ZACKS RESOURCES:

 

Manage your Profit from the Pros subscription:

Regards and Happy Investing,

Charles Rotblut, CFA
Senior Market Analyst
Zacks.com

p.s. What is the mission for Zacks Profit from the Pros? To find out how we will help you become a more successful investor, click here.

 

Visit /performance for information about the performance numbers displayed in this newsletter.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

To contact us by mail:

Zacks Investment Research
Attn: Profit from the Pros
111 N. Canal St., Suite 1101
Chicago, IL 60606

To unsubscribe from receiving "Zacks.com Profit from the Pros"
e-mail newsletter, Click here....

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.